BBA Advances : Impact Factor & More
eISSN: 2667-1603
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on BBA Advances
BBA Advances Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 2300 |
| Publication Time | 10 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in BBA Advances ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in BBA Advances
Purinergic Signaling Modulates Endothelial-to-Mesenchymal Transition in Human Aortic Valve Endothelial Cells
- 1 Apr 2026
- BBA Advances
Collateral lethality of NAD kinase in 1p36 deleted tumors drives vulnerability to NAD kinase 2 depletion.
- 1 Apr 2026
- BBA advances
Adjacent domains drive the emergence of misfolded intermediates in the folding pathway of the PDZ4 from MAGI1
- 1 Feb 2026
- BBA Advances
TCA cycle intermediates as an adjunct strategy for human iPSC-derived cardiomyocyte maturation.
- 1 Feb 2026
- BBA advances
Bioactive derivatives of the antimicrobial peptide esculentin-1a promote human dermal fibroblast migration and activate genes involved in early wound healing.
- 1 Jan 2026
- BBA advances
MiR-765 induces angiogenesis by inhibiting dipeptidyl peptidase 4 and increasing fibroblast growth factor 2.
- 1 Jan 2026
- BBA advances
Purinergic Signaling Modulates Endothelial-to-Mesenchymal Transition in Human Aortic Valve Endothelial Cells
- 1 Apr 2026
- BBA Advances
Collateral lethality of NAD kinase in 1p36 deleted tumors drives vulnerability to NAD kinase 2 depletion.
- 1 Apr 2026
- BBA advances
Adjacent domains drive the emergence of misfolded intermediates in the folding pathway of the PDZ4 from MAGI1
- 1 Feb 2026
- BBA Advances
TCA cycle intermediates as an adjunct strategy for human iPSC-derived cardiomyocyte maturation.
- 1 Feb 2026
- BBA advances
Bioactive derivatives of the antimicrobial peptide esculentin-1a promote human dermal fibroblast migration and activate genes involved in early wound healing.
- 1 Jan 2026
- BBA advances
MiR-765 induces angiogenesis by inhibiting dipeptidyl peptidase 4 and increasing fibroblast growth factor 2.
- 1 Jan 2026
- BBA advances
FAQs on BBA Advances
How many articles did BBA Advances publish last year? 
Who is the publisher of BBA Advances?
